Clinical Trials Browser

Phase 2 × Sorafenib × Lymphoid × Clear all

NCT01620216 2021-11-04

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Phase 2 Terminated

12 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01510756 2016-01-21

Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Phase 2 Terminated

4 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00131937 2015-09-03

Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

14 enrolled 7 charts

DermatologicLymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00303966 2014-05-07

Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Phase 2 Terminated

5 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00278382 2013-02-07

Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Phase 2 Completed

33 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell